Mutation in the promoter region of the β-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis

European Heart Journal

Volumn 22, Issue 24, 2001, Pages 2262-2266

  Blake, G J ^a   Schmitz, C ^b   Lindpaintner, K ^a,b   Ridker, Paul M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Fibrinogen promoter gene; Cardiovascular risk; Myocardial infarction; Stroke; Venous thrombosis

Indexed keywords

FIBRINOGEN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; GENE FREQUENCY; GENE MUTATION; HEART INFARCTION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; STROKE; THROMBOEMBOLISM; VEIN THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; CORONARY ARTERIOSCLEROSIS; DNA PRIMERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FIBRINOGEN; GENOTYPE; GERMANY; HUMANS; MALE; MASSACHUSETTS; MIDDLE AGED; MUTATION; MYOCARDIAL INFARCTION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SMOKING; VENOUS THROMBOSIS;

EID: 0035658140     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.2692     Document Type: Article

References (18)

1. Fibrinogen as a risk factor for stroke and myocardial infarction
2. A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study
3. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms - The Leiden Thrombophilia Study (LETS)
4. Regulation of fibrinogen assembly. Transfection of Hep G2 cells with B beta cDNA specifically enhances synthesis of the three component chains of fibrinogen
5. Polymorphisms of the beta fibrinogen gene and plasma fibrinogen concentration in Caucasian and Japanese population samples
6. Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration
7. Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM study. Etude cas-temoins sur l'infarctus du myocarde
8. Linkage disequilibrium relationships among four polymorphisms within the human fibrinogen gene cluster
9. Beta-fibrinogen gene polymorphism (C148T) is associated with carotid atherosclerosis: Results of the Austrian stroke prevention study
10. Genetic variation in the promoter region of the beta-fibrinogen gene is associated with ischemic stroke in a Japanese population
11. Betafibrinogen gene G/A-455 polymorphism in relation to fibrinogen concentrations and ischaemic heart disease in Chinese patients with type II diabetes
12. A common mutation (G-455-A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study
13. Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM study
14. Fibrinogen polymorphisms are not associated with the risk of myocardial infarction
15. Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis: Edinburgh Artery Study
16. Final report on the aspirin component of the ongoing Physicians' Health Study Steering Committee of the Physicians' Health Study Research Group
17. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men
18. European Atherosclerosis Research Study: Genotype at the fibrinogen locus (G-455-A beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender-genotype-environment interaction